nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ALB—asthma	0.175	1	CbGaD
Vemurafenib—ABCG2—Zafirlukast—asthma	0.048	0.0928	CbGbCtD
Vemurafenib—CYP1A2—Zileuton—asthma	0.0225	0.0434	CbGbCtD
Vemurafenib—CYP2D6—Ciclesonide—asthma	0.0224	0.0432	CbGbCtD
Vemurafenib—CYP1A2—Zafirlukast—asthma	0.0198	0.0383	CbGbCtD
Vemurafenib—ABCG2—Hydrocortisone—asthma	0.0195	0.0378	CbGbCtD
Vemurafenib—CYP2D6—Ipratropium bromide—asthma	0.0185	0.0358	CbGbCtD
Vemurafenib—CYP3A4—Fluticasone furoate—asthma	0.0174	0.0337	CbGbCtD
Vemurafenib—CYP2D6—Zafirlukast—asthma	0.0163	0.0315	CbGbCtD
Vemurafenib—CYP1A2—Aminophylline—asthma	0.0163	0.0314	CbGbCtD
Vemurafenib—CYP2D6—Arformoterol—asthma	0.0157	0.0304	CbGbCtD
Vemurafenib—CYP2D6—Formoterol—asthma	0.0157	0.0304	CbGbCtD
Vemurafenib—CYP3A4—Budesonide—asthma	0.0155	0.03	CbGbCtD
Vemurafenib—CYP1A2—Theophylline—asthma	0.0153	0.0295	CbGbCtD
Vemurafenib—CYP3A4—Indacaterol—asthma	0.0142	0.0275	CbGbCtD
Vemurafenib—CYP3A4—Ciclesonide—asthma	0.0142	0.0275	CbGbCtD
Vemurafenib—CYP2D6—Tiotropium—asthma	0.014	0.0271	CbGbCtD
Vemurafenib—ALB—Prednisone—asthma	0.0134	0.0259	CbGbCtD
Vemurafenib—CYP3A4—Salbutamol—asthma	0.0132	0.0255	CbGbCtD
Vemurafenib—CYP3A4—Flunisolide—asthma	0.0132	0.0255	CbGbCtD
Vemurafenib—CYP3A4—Salmeterol—asthma	0.0132	0.0255	CbGbCtD
Vemurafenib—CYP2D6—Theophylline—asthma	0.0126	0.0243	CbGbCtD
Vemurafenib—ABCG2—Dexamethasone—asthma	0.0122	0.0235	CbGbCtD
Vemurafenib—CYP2D6—Loratadine—asthma	0.0119	0.0231	CbGbCtD
Vemurafenib—CYP3A4—Ipratropium bromide—asthma	0.0118	0.0228	CbGbCtD
Vemurafenib—CYP3A4—Zileuton—asthma	0.0118	0.0228	CbGbCtD
Vemurafenib—CYP3A4—Fluticasone Propionate—asthma	0.0112	0.0217	CbGbCtD
Vemurafenib—CYP3A4—Zafirlukast—asthma	0.0104	0.02	CbGbCtD
Vemurafenib—CYP3A4—Tiotropium—asthma	0.00893	0.0173	CbGbCtD
Vemurafenib—CYP3A4—Aminophylline—asthma	0.00851	0.0165	CbGbCtD
Vemurafenib—CYP3A4—Theophylline—asthma	0.00801	0.0155	CbGbCtD
Vemurafenib—CYP3A4—Loratadine—asthma	0.00759	0.0147	CbGbCtD
Vemurafenib—CYP3A4—Montelukast—asthma	0.00759	0.0147	CbGbCtD
Vemurafenib—CYP3A4—Methylprednisolone—asthma	0.00694	0.0134	CbGbCtD
Vemurafenib—CYP3A4—Triamcinolone—asthma	0.00526	0.0102	CbGbCtD
Vemurafenib—CYP3A4—Betamethasone—asthma	0.00451	0.00872	CbGbCtD
Vemurafenib—ORM1—saliva—asthma	0.00451	0.173	CbGeAlD
Vemurafenib—CYP3A4—Prednisolone—asthma	0.00445	0.00861	CbGbCtD
Vemurafenib—CYP3A4—Hydrocortisone—asthma	0.00422	0.00816	CbGbCtD
Vemurafenib—CYP3A4—Prednisone—asthma	0.00421	0.00813	CbGbCtD
Vemurafenib—CYP2D6—Dexamethasone—asthma	0.00413	0.00798	CbGbCtD
Vemurafenib—CYP3A4—Dexamethasone—asthma	0.00263	0.00507	CbGbCtD
Vemurafenib—RAF1—respiratory system—asthma	0.00172	0.0658	CbGeAlD
Vemurafenib—BRAF—adrenal gland—asthma	0.00156	0.0598	CbGeAlD
Vemurafenib—RAF1—adrenal cortex—asthma	0.00144	0.0552	CbGeAlD
Vemurafenib—RAF1—epithelium—asthma	0.00144	0.055	CbGeAlD
Vemurafenib—RAF1—bronchus—asthma	0.00141	0.0541	CbGeAlD
Vemurafenib—RAF1—smooth muscle tissue—asthma	0.00138	0.053	CbGeAlD
Vemurafenib—BRAF—lung—asthma	0.00137	0.0524	CbGeAlD
Vemurafenib—RAF1—cardiovascular system—asthma	0.00132	0.0504	CbGeAlD
Vemurafenib—RAF1—trachea—asthma	0.00127	0.0486	CbGeAlD
Vemurafenib—RAF1—adrenal gland—asthma	0.00104	0.0399	CbGeAlD
Vemurafenib—RAF1—lung—asthma	0.000912	0.0349	CbGeAlD
Vemurafenib—ABCC1—adrenal cortex—asthma	0.000721	0.0276	CbGeAlD
Vemurafenib—ABCC1—bronchus—asthma	0.000707	0.0271	CbGeAlD
Vemurafenib—Etoricoxib—PTGS2—asthma	0.000706	1	CrCbGaD
Vemurafenib—CYP1A2—respiratory system—asthma	0.000684	0.0262	CbGeAlD
Vemurafenib—ABCC1—trachea—asthma	0.000634	0.0243	CbGeAlD
Vemurafenib—ALB—adrenal gland—asthma	0.00063	0.0241	CbGeAlD
Vemurafenib—ORM1—lung—asthma	0.00063	0.0241	CbGeAlD
Vemurafenib—ABCG2—adrenal cortex—asthma	0.000596	0.0228	CbGeAlD
Vemurafenib—ABCC1—adrenal gland—asthma	0.00052	0.0199	CbGeAlD
Vemurafenib—ABCC1—lung—asthma	0.000456	0.0175	CbGeAlD
Vemurafenib—ABCG2—adrenal gland—asthma	0.000431	0.0165	CbGeAlD
Vemurafenib—ABCG2—lung—asthma	0.000377	0.0144	CbGeAlD
Vemurafenib—CYP1A2—lung—asthma	0.000363	0.0139	CbGeAlD
Vemurafenib—Decreased appetite—Budesonide—asthma	0.000127	0.000756	CcSEcCtD
Vemurafenib—Body temperature increased—Arformoterol—asthma	0.000127	0.000752	CcSEcCtD
Vemurafenib—Body temperature increased—Formoterol—asthma	0.000127	0.000752	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Budesonide—asthma	0.000127	0.000751	CcSEcCtD
Vemurafenib—Vomiting—Loratadine—asthma	0.000127	0.000751	CcSEcCtD
Vemurafenib—Fatigue—Budesonide—asthma	0.000126	0.00075	CcSEcCtD
Vemurafenib—Vomiting—Tiotropium—asthma	0.000126	0.00075	CcSEcCtD
Vemurafenib—Diarrhoea—Flunisolide—asthma	0.000126	0.000748	CcSEcCtD
Vemurafenib—Rash—Loratadine—asthma	0.000125	0.000745	CcSEcCtD
Vemurafenib—Constipation—Budesonide—asthma	0.000125	0.000744	CcSEcCtD
Vemurafenib—Dermatitis—Loratadine—asthma	0.000125	0.000744	CcSEcCtD
Vemurafenib—Rash—Tiotropium—asthma	0.000125	0.000743	CcSEcCtD
Vemurafenib—Dermatitis—Tiotropium—asthma	0.000125	0.000743	CcSEcCtD
Vemurafenib—Nausea—Aminophylline—asthma	0.000125	0.000743	CcSEcCtD
Vemurafenib—Infestation—Methylprednisolone—asthma	0.000125	0.000741	CcSEcCtD
Vemurafenib—Infestation NOS—Methylprednisolone—asthma	0.000125	0.000741	CcSEcCtD
Vemurafenib—Headache—Loratadine—asthma	0.000125	0.00074	CcSEcCtD
Vemurafenib—Headache—Tiotropium—asthma	0.000124	0.000738	CcSEcCtD
Vemurafenib—Body temperature increased—Montelukast—asthma	0.000124	0.000737	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Triamcinolone—asthma	0.000123	0.000728	CcSEcCtD
Vemurafenib—Asthenia—Mometasone—asthma	0.000123	0.000727	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Methylprednisolone—asthma	0.000122	0.000727	CcSEcCtD
Vemurafenib—Dizziness—Flunisolide—asthma	0.000122	0.000723	CcSEcCtD
Vemurafenib—Pruritus—Mometasone—asthma	0.000121	0.000717	CcSEcCtD
Vemurafenib—Body temperature increased—Salbutamol—asthma	0.00012	0.00071	CcSEcCtD
Vemurafenib—Nausea—Loratadine—asthma	0.000118	0.000701	CcSEcCtD
Vemurafenib—Hypersensitivity—Formoterol—asthma	0.000118	0.000701	CcSEcCtD
Vemurafenib—Hypersensitivity—Arformoterol—asthma	0.000118	0.000701	CcSEcCtD
Vemurafenib—Nausea—Tiotropium—asthma	0.000118	0.0007	CcSEcCtD
Vemurafenib—Dry skin—Prednisone—asthma	0.000118	0.000698	CcSEcCtD
Vemurafenib—Connective tissue disorder—Hydrocortisone—asthma	0.000117	0.000696	CcSEcCtD
Vemurafenib—Vomiting—Flunisolide—asthma	0.000117	0.000695	CcSEcCtD
Vemurafenib—Diarrhoea—Mometasone—asthma	0.000117	0.000693	CcSEcCtD
Vemurafenib—Rash—Flunisolide—asthma	0.000116	0.000689	CcSEcCtD
Vemurafenib—Dermatitis—Flunisolide—asthma	0.000116	0.000688	CcSEcCtD
Vemurafenib—Body temperature increased—Budesonide—asthma	0.000116	0.000688	CcSEcCtD
Vemurafenib—Hypersensitivity—Montelukast—asthma	0.000116	0.000687	CcSEcCtD
Vemurafenib—Headache—Flunisolide—asthma	0.000115	0.000684	CcSEcCtD
Vemurafenib—Weight decreased—Betamethasone—asthma	0.000115	0.000684	CcSEcCtD
Vemurafenib—Weight decreased—Dexamethasone—asthma	0.000115	0.000684	CcSEcCtD
Vemurafenib—Asthenia—Formoterol—asthma	0.000115	0.000683	CcSEcCtD
Vemurafenib—Asthenia—Arformoterol—asthma	0.000115	0.000683	CcSEcCtD
Vemurafenib—Pruritus—Arformoterol—asthma	0.000113	0.000673	CcSEcCtD
Vemurafenib—Pruritus—Formoterol—asthma	0.000113	0.000673	CcSEcCtD
Vemurafenib—Asthenia—Montelukast—asthma	0.000113	0.000669	CcSEcCtD
Vemurafenib—Eye disorder—Hydrocortisone—asthma	0.000112	0.000662	CcSEcCtD
Vemurafenib—Hypersensitivity—Salbutamol—asthma	0.000112	0.000662	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Dexamethasone—asthma	0.000111	0.000661	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Betamethasone—asthma	0.000111	0.000661	CcSEcCtD
Vemurafenib—Pruritus—Montelukast—asthma	0.000111	0.000659	CcSEcCtD
Vemurafenib—Connective tissue disorder—Methylprednisolone—asthma	0.00011	0.000654	CcSEcCtD
Vemurafenib—Diarrhoea—Arformoterol—asthma	0.00011	0.000651	CcSEcCtD
Vemurafenib—Diarrhoea—Formoterol—asthma	0.00011	0.000651	CcSEcCtD
Vemurafenib—Nausea—Flunisolide—asthma	0.000109	0.000649	CcSEcCtD
Vemurafenib—Asthenia—Salbutamol—asthma	0.000109	0.000645	CcSEcCtD
Vemurafenib—Vomiting—Mometasone—asthma	0.000109	0.000644	CcSEcCtD
Vemurafenib—Hypersensitivity—Budesonide—asthma	0.000108	0.000641	CcSEcCtD
Vemurafenib—Rash—Mometasone—asthma	0.000108	0.000639	CcSEcCtD
Vemurafenib—Dermatitis—Mometasone—asthma	0.000108	0.000638	CcSEcCtD
Vemurafenib—Diarrhoea—Montelukast—asthma	0.000107	0.000638	CcSEcCtD
Vemurafenib—Pruritus—Salbutamol—asthma	0.000107	0.000636	CcSEcCtD
Vemurafenib—Headache—Mometasone—asthma	0.000107	0.000635	CcSEcCtD
Vemurafenib—Erythema—Prednisolone—asthma	0.000106	0.000631	CcSEcCtD
Vemurafenib—Dizziness—Arformoterol—asthma	0.000106	0.000629	CcSEcCtD
Vemurafenib—Dizziness—Formoterol—asthma	0.000106	0.000629	CcSEcCtD
Vemurafenib—Asthenia—Budesonide—asthma	0.000105	0.000624	CcSEcCtD
Vemurafenib—Eye disorder—Methylprednisolone—asthma	0.000105	0.000622	CcSEcCtD
Vemurafenib—Cardiac disorder—Methylprednisolone—asthma	0.000104	0.000618	CcSEcCtD
Vemurafenib—Erythema—Hydrocortisone—asthma	0.000104	0.000617	CcSEcCtD
Vemurafenib—Malnutrition—Hydrocortisone—asthma	0.000104	0.000617	CcSEcCtD
Vemurafenib—Dizziness—Montelukast—asthma	0.000104	0.000616	CcSEcCtD
Vemurafenib—Pruritus—Budesonide—asthma	0.000104	0.000616	CcSEcCtD
Vemurafenib—Diarrhoea—Salbutamol—asthma	0.000104	0.000615	CcSEcCtD
Vemurafenib—Vomiting—Arformoterol—asthma	0.000102	0.000605	CcSEcCtD
Vemurafenib—Vomiting—Formoterol—asthma	0.000102	0.000605	CcSEcCtD
Vemurafenib—Angiopathy—Methylprednisolone—asthma	0.000102	0.000604	CcSEcCtD
Vemurafenib—Nausea—Mometasone—asthma	0.000101	0.000602	CcSEcCtD
Vemurafenib—Rash—Formoterol—asthma	0.000101	0.0006	CcSEcCtD
Vemurafenib—Rash—Arformoterol—asthma	0.000101	0.0006	CcSEcCtD
Vemurafenib—Mediastinal disorder—Methylprednisolone—asthma	0.000101	0.0006	CcSEcCtD
Vemurafenib—Dermatitis—Arformoterol—asthma	0.000101	0.000599	CcSEcCtD
Vemurafenib—Dermatitis—Formoterol—asthma	0.000101	0.000599	CcSEcCtD
Vemurafenib—Headache—Formoterol—asthma	0.0001	0.000596	CcSEcCtD
Vemurafenib—Headache—Arformoterol—asthma	0.0001	0.000596	CcSEcCtD
Vemurafenib—Weight decreased—Prednisone—asthma	0.0001	0.000596	CcSEcCtD
Vemurafenib—Diarrhoea—Budesonide—asthma	0.0001	0.000595	CcSEcCtD
Vemurafenib—Dizziness—Salbutamol—asthma	0.0001	0.000594	CcSEcCtD
Vemurafenib—Vomiting—Montelukast—asthma	9.99e-05	0.000592	CcSEcCtD
Vemurafenib—Rash—Montelukast—asthma	9.9e-05	0.000588	CcSEcCtD
Vemurafenib—Dermatitis—Montelukast—asthma	9.89e-05	0.000587	CcSEcCtD
Vemurafenib—Headache—Montelukast—asthma	9.84e-05	0.000584	CcSEcCtD
Vemurafenib—Erythema—Triamcinolone—asthma	9.78e-05	0.000581	CcSEcCtD
Vemurafenib—Malnutrition—Methylprednisolone—asthma	9.76e-05	0.000579	CcSEcCtD
Vemurafenib—Erythema—Methylprednisolone—asthma	9.76e-05	0.000579	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Prednisone—asthma	9.7e-05	0.000575	CcSEcCtD
Vemurafenib—Dizziness—Budesonide—asthma	9.7e-05	0.000575	CcSEcCtD
Vemurafenib—Vomiting—Salbutamol—asthma	9.63e-05	0.000571	CcSEcCtD
Vemurafenib—Dysgeusia—Triamcinolone—asthma	9.58e-05	0.000569	CcSEcCtD
Vemurafenib—Rash—Salbutamol—asthma	9.55e-05	0.000566	CcSEcCtD
Vemurafenib—Dermatitis—Salbutamol—asthma	9.54e-05	0.000566	CcSEcCtD
Vemurafenib—Eye disorder—Dexamethasone—asthma	9.53e-05	0.000566	CcSEcCtD
Vemurafenib—Eye disorder—Betamethasone—asthma	9.53e-05	0.000566	CcSEcCtD
Vemurafenib—Nausea—Formoterol—asthma	9.52e-05	0.000565	CcSEcCtD
Vemurafenib—Nausea—Arformoterol—asthma	9.52e-05	0.000565	CcSEcCtD
Vemurafenib—Headache—Salbutamol—asthma	9.48e-05	0.000563	CcSEcCtD
Vemurafenib—Back pain—Triamcinolone—asthma	9.46e-05	0.000562	CcSEcCtD
Vemurafenib—Nausea—Montelukast—asthma	9.33e-05	0.000554	CcSEcCtD
Vemurafenib—Vomiting—Budesonide—asthma	9.32e-05	0.000553	CcSEcCtD
Vemurafenib—Angiopathy—Dexamethasone—asthma	9.25e-05	0.000549	CcSEcCtD
Vemurafenib—Angiopathy—Betamethasone—asthma	9.25e-05	0.000549	CcSEcCtD
Vemurafenib—Rash—Budesonide—asthma	9.25e-05	0.000549	CcSEcCtD
Vemurafenib—Dermatitis—Budesonide—asthma	9.24e-05	0.000548	CcSEcCtD
Vemurafenib—Headache—Budesonide—asthma	9.19e-05	0.000545	CcSEcCtD
Vemurafenib—Alopecia—Dexamethasone—asthma	9.01e-05	0.000535	CcSEcCtD
Vemurafenib—Alopecia—Betamethasone—asthma	9.01e-05	0.000535	CcSEcCtD
Vemurafenib—Nausea—Salbutamol—asthma	8.99e-05	0.000534	CcSEcCtD
Vemurafenib—Erythema—Dexamethasone—asthma	8.88e-05	0.000527	CcSEcCtD
Vemurafenib—Erythema—Betamethasone—asthma	8.88e-05	0.000527	CcSEcCtD
Vemurafenib—Myalgia—Hydrocortisone—asthma	8.85e-05	0.000525	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	8.79e-05	0.000521	CcSEcCtD
Vemurafenib—Connective tissue disorder—Prednisone—asthma	8.73e-05	0.000518	CcSEcCtD
Vemurafenib—Nausea—Budesonide—asthma	8.71e-05	0.000517	CcSEcCtD
Vemurafenib—Anaphylactic shock—Prednisolone—asthma	8.68e-05	0.000515	CcSEcCtD
Vemurafenib—Cough—Triamcinolone—asthma	8.54e-05	0.000507	CcSEcCtD
Vemurafenib—Anaphylactic shock—Hydrocortisone—asthma	8.48e-05	0.000503	CcSEcCtD
Vemurafenib—Infection—Hydrocortisone—asthma	8.43e-05	0.0005	CcSEcCtD
Vemurafenib—Myalgia—Triamcinolone—asthma	8.33e-05	0.000494	CcSEcCtD
Vemurafenib—Nervous system disorder—Hydrocortisone—asthma	8.32e-05	0.000493	CcSEcCtD
Vemurafenib—Arthralgia—Methylprednisolone—asthma	8.31e-05	0.000493	CcSEcCtD
Vemurafenib—Myalgia—Methylprednisolone—asthma	8.31e-05	0.000493	CcSEcCtD
Vemurafenib—Eye disorder—Prednisone—asthma	8.3e-05	0.000492	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	8.25e-05	0.00049	CcSEcCtD
Vemurafenib—Skin disorder—Hydrocortisone—asthma	8.24e-05	0.000489	CcSEcCtD
Vemurafenib—Angiopathy—Prednisone—asthma	8.06e-05	0.000478	CcSEcCtD
Vemurafenib—Anaphylactic shock—Triamcinolone—asthma	7.99e-05	0.000474	CcSEcCtD
Vemurafenib—Anaphylactic shock—Methylprednisolone—asthma	7.97e-05	0.000473	CcSEcCtD
Vemurafenib—Infection—Triamcinolone—asthma	7.93e-05	0.000471	CcSEcCtD
Vemurafenib—Hypotension—Hydrocortisone—asthma	7.92e-05	0.00047	CcSEcCtD
Vemurafenib—Infection—Methylprednisolone—asthma	7.92e-05	0.00047	CcSEcCtD
Vemurafenib—Alopecia—Prednisone—asthma	7.85e-05	0.000466	CcSEcCtD
Vemurafenib—Nervous system disorder—Methylprednisolone—asthma	7.81e-05	0.000464	CcSEcCtD
Vemurafenib—Skin disorder—Methylprednisolone—asthma	7.74e-05	0.000459	CcSEcCtD
Vemurafenib—Erythema—Prednisone—asthma	7.73e-05	0.000459	CcSEcCtD
Vemurafenib—Malnutrition—Prednisone—asthma	7.73e-05	0.000459	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Hydrocortisone—asthma	7.73e-05	0.000458	CcSEcCtD
Vemurafenib—Myalgia—Dexamethasone—asthma	7.56e-05	0.000448	CcSEcCtD
Vemurafenib—Myalgia—Betamethasone—asthma	7.56e-05	0.000448	CcSEcCtD
Vemurafenib—Hypotension—Methylprednisolone—asthma	7.45e-05	0.000442	CcSEcCtD
Vemurafenib—Decreased appetite—Hydrocortisone—asthma	7.37e-05	0.000437	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Hydrocortisone—asthma	7.32e-05	0.000434	CcSEcCtD
Vemurafenib—Fatigue—Hydrocortisone—asthma	7.31e-05	0.000434	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Triamcinolone—asthma	7.28e-05	0.000432	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Methylprednisolone—asthma	7.26e-05	0.000431	CcSEcCtD
Vemurafenib—Anaphylactic shock—Betamethasone—asthma	7.25e-05	0.00043	CcSEcCtD
Vemurafenib—Anaphylactic shock—Dexamethasone—asthma	7.25e-05	0.00043	CcSEcCtD
Vemurafenib—Infection—Dexamethasone—asthma	7.2e-05	0.000427	CcSEcCtD
Vemurafenib—Infection—Betamethasone—asthma	7.2e-05	0.000427	CcSEcCtD
Vemurafenib—Nervous system disorder—Betamethasone—asthma	7.11e-05	0.000422	CcSEcCtD
Vemurafenib—Nervous system disorder—Dexamethasone—asthma	7.11e-05	0.000422	CcSEcCtD
Vemurafenib—Fatigue—Triamcinolone—asthma	6.88e-05	0.000409	CcSEcCtD
Vemurafenib—Fatigue—Methylprednisolone—asthma	6.87e-05	0.000408	CcSEcCtD
Vemurafenib—Hypotension—Betamethasone—asthma	6.77e-05	0.000402	CcSEcCtD
Vemurafenib—Hypotension—Dexamethasone—asthma	6.77e-05	0.000402	CcSEcCtD
Vemurafenib—Body temperature increased—Hydrocortisone—asthma	6.7e-05	0.000398	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Betamethasone—asthma	6.6e-05	0.000392	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Dexamethasone—asthma	6.6e-05	0.000392	CcSEcCtD
Vemurafenib—Myalgia—Prednisone—asthma	6.58e-05	0.000391	CcSEcCtD
Vemurafenib—Arthralgia—Prednisone—asthma	6.58e-05	0.000391	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	6.54e-05	0.000388	CcSEcCtD
Vemurafenib—Hypersensitivity—Prednisolone—asthma	6.4e-05	0.00038	CcSEcCtD
Vemurafenib—Body temperature increased—Triamcinolone—asthma	6.31e-05	0.000375	CcSEcCtD
Vemurafenib—Anaphylactic shock—Prednisone—asthma	6.31e-05	0.000374	CcSEcCtD
Vemurafenib—Decreased appetite—Dexamethasone—asthma	6.3e-05	0.000374	CcSEcCtD
Vemurafenib—Decreased appetite—Betamethasone—asthma	6.3e-05	0.000374	CcSEcCtD
Vemurafenib—Infection—Prednisone—asthma	6.27e-05	0.000372	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Betamethasone—asthma	6.26e-05	0.000371	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Dexamethasone—asthma	6.26e-05	0.000371	CcSEcCtD
Vemurafenib—Hypersensitivity—Hydrocortisone—asthma	6.25e-05	0.000371	CcSEcCtD
Vemurafenib—Fatigue—Dexamethasone—asthma	6.25e-05	0.000371	CcSEcCtD
Vemurafenib—Fatigue—Betamethasone—asthma	6.25e-05	0.000371	CcSEcCtD
Vemurafenib—Nervous system disorder—Prednisone—asthma	6.19e-05	0.000367	CcSEcCtD
Vemurafenib—Skin disorder—Prednisone—asthma	6.13e-05	0.000364	CcSEcCtD
Vemurafenib—Asthenia—Hydrocortisone—asthma	6.08e-05	0.000361	CcSEcCtD
Vemurafenib—Pruritus—Hydrocortisone—asthma	6e-05	0.000356	CcSEcCtD
Vemurafenib—Hypersensitivity—Triamcinolone—asthma	5.88e-05	0.000349	CcSEcCtD
Vemurafenib—Hypersensitivity—Methylprednisolone—asthma	5.87e-05	0.000348	CcSEcCtD
Vemurafenib—Diarrhoea—Hydrocortisone—asthma	5.8e-05	0.000344	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Prednisone—asthma	5.75e-05	0.000341	CcSEcCtD
Vemurafenib—Dizziness—Prednisolone—asthma	5.74e-05	0.000341	CcSEcCtD
Vemurafenib—Asthenia—Triamcinolone—asthma	5.73e-05	0.00034	CcSEcCtD
Vemurafenib—Body temperature increased—Betamethasone—asthma	5.73e-05	0.00034	CcSEcCtD
Vemurafenib—Body temperature increased—Dexamethasone—asthma	5.73e-05	0.00034	CcSEcCtD
Vemurafenib—Asthenia—Methylprednisolone—asthma	5.72e-05	0.000339	CcSEcCtD
Vemurafenib—Pruritus—Triamcinolone—asthma	5.65e-05	0.000335	CcSEcCtD
Vemurafenib—Pruritus—Methylprednisolone—asthma	5.64e-05	0.000334	CcSEcCtD
Vemurafenib—Dizziness—Hydrocortisone—asthma	5.61e-05	0.000333	CcSEcCtD
Vemurafenib—Decreased appetite—Prednisone—asthma	5.49e-05	0.000325	CcSEcCtD
Vemurafenib—Rash—Prednisolone—asthma	5.48e-05	0.000325	CcSEcCtD
Vemurafenib—Dermatitis—Prednisolone—asthma	5.47e-05	0.000325	CcSEcCtD
Vemurafenib—Diarrhoea—Methylprednisolone—asthma	5.45e-05	0.000323	CcSEcCtD
Vemurafenib—Fatigue—Prednisone—asthma	5.44e-05	0.000323	CcSEcCtD
Vemurafenib—Headache—Prednisolone—asthma	5.44e-05	0.000323	CcSEcCtD
Vemurafenib—Constipation—Prednisone—asthma	5.4e-05	0.00032	CcSEcCtD
Vemurafenib—Vomiting—Hydrocortisone—asthma	5.39e-05	0.00032	CcSEcCtD
Vemurafenib—Rash—Hydrocortisone—asthma	5.35e-05	0.000317	CcSEcCtD
Vemurafenib—Dermatitis—Hydrocortisone—asthma	5.34e-05	0.000317	CcSEcCtD
Vemurafenib—Headache—Hydrocortisone—asthma	5.31e-05	0.000315	CcSEcCtD
Vemurafenib—Dizziness—Triamcinolone—asthma	5.28e-05	0.000313	CcSEcCtD
Vemurafenib—Dizziness—Methylprednisolone—asthma	5.27e-05	0.000313	CcSEcCtD
Vemurafenib—Asthenia—Dexamethasone—asthma	5.2e-05	0.000308	CcSEcCtD
Vemurafenib—Asthenia—Betamethasone—asthma	5.2e-05	0.000308	CcSEcCtD
Vemurafenib—Nausea—Prednisolone—asthma	5.16e-05	0.000306	CcSEcCtD
Vemurafenib—Pruritus—Betamethasone—asthma	5.13e-05	0.000304	CcSEcCtD
Vemurafenib—Pruritus—Dexamethasone—asthma	5.13e-05	0.000304	CcSEcCtD
Vemurafenib—Vomiting—Triamcinolone—asthma	5.08e-05	0.000301	CcSEcCtD
Vemurafenib—Vomiting—Methylprednisolone—asthma	5.07e-05	0.000301	CcSEcCtD
Vemurafenib—Nausea—Hydrocortisone—asthma	5.04e-05	0.000299	CcSEcCtD
Vemurafenib—Rash—Triamcinolone—asthma	5.03e-05	0.000299	CcSEcCtD
Vemurafenib—Dermatitis—Triamcinolone—asthma	5.03e-05	0.000298	CcSEcCtD
Vemurafenib—Rash—Methylprednisolone—asthma	5.02e-05	0.000298	CcSEcCtD
Vemurafenib—Dermatitis—Methylprednisolone—asthma	5.02e-05	0.000298	CcSEcCtD
Vemurafenib—Headache—Triamcinolone—asthma	5e-05	0.000297	CcSEcCtD
Vemurafenib—Headache—Methylprednisolone—asthma	4.99e-05	0.000296	CcSEcCtD
Vemurafenib—Body temperature increased—Prednisone—asthma	4.99e-05	0.000296	CcSEcCtD
Vemurafenib—Diarrhoea—Dexamethasone—asthma	4.96e-05	0.000294	CcSEcCtD
Vemurafenib—Diarrhoea—Betamethasone—asthma	4.96e-05	0.000294	CcSEcCtD
Vemurafenib—Dizziness—Dexamethasone—asthma	4.79e-05	0.000284	CcSEcCtD
Vemurafenib—Dizziness—Betamethasone—asthma	4.79e-05	0.000284	CcSEcCtD
Vemurafenib—Nausea—Triamcinolone—asthma	4.74e-05	0.000281	CcSEcCtD
Vemurafenib—Nausea—Methylprednisolone—asthma	4.73e-05	0.000281	CcSEcCtD
Vemurafenib—Hypersensitivity—Prednisone—asthma	4.65e-05	0.000276	CcSEcCtD
Vemurafenib—Vomiting—Betamethasone—asthma	4.61e-05	0.000273	CcSEcCtD
Vemurafenib—Vomiting—Dexamethasone—asthma	4.61e-05	0.000273	CcSEcCtD
Vemurafenib—Rash—Dexamethasone—asthma	4.57e-05	0.000271	CcSEcCtD
Vemurafenib—Rash—Betamethasone—asthma	4.57e-05	0.000271	CcSEcCtD
Vemurafenib—Dermatitis—Dexamethasone—asthma	4.56e-05	0.000271	CcSEcCtD
Vemurafenib—Dermatitis—Betamethasone—asthma	4.56e-05	0.000271	CcSEcCtD
Vemurafenib—Headache—Dexamethasone—asthma	4.54e-05	0.000269	CcSEcCtD
Vemurafenib—Headache—Betamethasone—asthma	4.54e-05	0.000269	CcSEcCtD
Vemurafenib—Asthenia—Prednisone—asthma	4.53e-05	0.000269	CcSEcCtD
Vemurafenib—Pruritus—Prednisone—asthma	4.46e-05	0.000265	CcSEcCtD
Vemurafenib—Diarrhoea—Prednisone—asthma	4.32e-05	0.000256	CcSEcCtD
Vemurafenib—Nausea—Dexamethasone—asthma	4.3e-05	0.000255	CcSEcCtD
Vemurafenib—Nausea—Betamethasone—asthma	4.3e-05	0.000255	CcSEcCtD
Vemurafenib—Dizziness—Prednisone—asthma	4.17e-05	0.000248	CcSEcCtD
Vemurafenib—Vomiting—Prednisone—asthma	4.01e-05	0.000238	CcSEcCtD
Vemurafenib—Rash—Prednisone—asthma	3.98e-05	0.000236	CcSEcCtD
Vemurafenib—Dermatitis—Prednisone—asthma	3.97e-05	0.000236	CcSEcCtD
Vemurafenib—Headache—Prednisone—asthma	3.95e-05	0.000235	CcSEcCtD
Vemurafenib—Nausea—Prednisone—asthma	3.75e-05	0.000222	CcSEcCtD
Vemurafenib—ABCC1—Disease—CCR5—asthma	1.15e-05	0.000102	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—C3—asthma	1.15e-05	0.000102	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ADCY2—asthma	1.15e-05	0.000102	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL3—asthma	1.14e-05	0.000102	CbGpPWpGaD
Vemurafenib—BRAF—Disease—NOS3—asthma	1.14e-05	0.000102	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—HMOX1—asthma	1.14e-05	0.000102	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ITPR1—asthma	1.14e-05	0.000102	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—TGFB1—asthma	1.13e-05	0.0001	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CAT—asthma	1.13e-05	0.0001	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—PTEN—asthma	1.12e-05	0.0001	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—TLR4—asthma	1.12e-05	9.98e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HLA-DRB1—asthma	1.12e-05	9.97e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—PDGFB—asthma	1.12e-05	9.95e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—FN1—asthma	1.1e-05	9.86e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PDGFB—asthma	1.1e-05	9.83e-05	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—TGFB1—asthma	1.1e-05	9.81e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PDGFB—asthma	1.09e-05	9.74e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—NOS2—asthma	1.09e-05	9.74e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ALDH7A1—asthma	1.08e-05	9.63e-05	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—TGFB1—asthma	1.08e-05	9.62e-05	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—EGFR—asthma	1.08e-05	9.62e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—KNG1—asthma	1.08e-05	9.61e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—POMC—asthma	1.07e-05	9.58e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—ICAM1—asthma	1.07e-05	9.57e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—AGTR1—asthma	1.07e-05	9.55e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—LEP—asthma	1.07e-05	9.52e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PLA2G4A—asthma	1.06e-05	9.49e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GSTM1—asthma	1.06e-05	9.49e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—LTA4H—asthma	1.05e-05	9.4e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CD4—asthma	1.05e-05	9.38e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CCL2—asthma	1.05e-05	9.37e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL6R—asthma	1.05e-05	9.34e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CXCL10—asthma	1.05e-05	9.33e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—PTGS2—asthma	1.04e-05	9.31e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ALOX5—asthma	1.04e-05	9.3e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ARG2—asthma	1.03e-05	9.23e-05	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—TNF—asthma	1.03e-05	9.16e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NTRK1—asthma	1.03e-05	9.16e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GSTP1—asthma	1.02e-05	9.08e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ADRB2—asthma	1.02e-05	9.06e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ALOX5AP—asthma	1.01e-05	9.03e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ALOX15—asthma	1.01e-05	9.03e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—FN1—asthma	1.01e-05	8.98e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—HMOX1—asthma	1e-05	8.96e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ITPR1—asthma	1e-05	8.94e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CARM1—asthma	9.94e-06	8.87e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CAT—asthma	9.91e-06	8.84e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—NOS2—asthma	9.82e-06	8.76e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—DCN—asthma	9.8e-06	8.74e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PPP2CA—asthma	9.79e-06	8.74e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—NOS2—asthma	9.73e-06	8.69e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CHAT—asthma	9.65e-06	8.61e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ITPR1—asthma	9.6e-06	8.57e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL6R—asthma	9.56e-06	8.53e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ALDH2—asthma	9.53e-06	8.5e-05	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—EGFR—asthma	9.52e-06	8.49e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—RHOA—asthma	9.46e-06	8.44e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PLA2G4A—asthma	9.36e-06	8.35e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GSTM1—asthma	9.36e-06	8.35e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ARG1—asthma	9.21e-06	8.22e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—SERPINE1—asthma	9.19e-06	8.2e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—POMC—asthma	9.16e-06	8.18e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—POMC—asthma	9.16e-06	8.18e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CD86—asthma	9.15e-06	8.16e-05	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—EGFR—asthma	9.14e-06	8.16e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—PTEN—asthma	9.1e-06	8.12e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—EDN1—asthma	9.07e-06	8.1e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	9.07e-06	8.09e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GSTT1—asthma	9.06e-06	8.09e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCL5—asthma	9e-06	8.03e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PLA2G4A—asthma	8.97e-06	8e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCL2—asthma	8.97e-06	8e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL6R—asthma	8.94e-06	7.98e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CSF2—asthma	8.87e-06	7.91e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—RHOA—asthma	8.87e-06	7.91e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—IL6R—asthma	8.83e-06	7.88e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—NOS3—asthma	8.78e-06	7.83e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—IL6R—asthma	8.75e-06	7.81e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SMAD3—asthma	8.63e-06	7.7e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PPP2CA—asthma	8.62e-06	7.69e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ALOX5—asthma	8.6e-06	7.68e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ALOX15—asthma	8.57e-06	7.65e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ALOX5AP—asthma	8.57e-06	7.65e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—SERPINE1—asthma	8.37e-06	7.47e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ALDH7A1—asthma	8.33e-06	7.43e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CXCL8—asthma	8.3e-06	7.41e-05	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—IL6—asthma	8.28e-06	7.39e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—SERPINE1—asthma	8.27e-06	7.38e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PPP2CA—asthma	8.26e-06	7.37e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—BCL2—asthma	8.23e-06	7.35e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CARM1—asthma	8.21e-06	7.32e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—SERPINE1—asthma	8.2e-06	7.31e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CHAT—asthma	8.18e-06	7.3e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IFNG—asthma	8.16e-06	7.28e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—STAT3—asthma	8.14e-06	7.26e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCR5—asthma	8.11e-06	7.24e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—DCN—asthma	8.09e-06	7.22e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—RHOA—asthma	8.07e-06	7.2e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL2RA—asthma	7.99e-06	7.13e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NOS3—asthma	7.99e-06	7.13e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ARG2—asthma	7.98e-06	7.12e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—RHOA—asthma	7.98e-06	7.12e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL2—asthma	7.93e-06	7.08e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—C3—asthma	7.93e-06	7.07e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—RHOA—asthma	7.91e-06	7.06e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—NOS3—asthma	7.89e-06	7.04e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD4—asthma	7.88e-06	7.03e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ALDH2—asthma	7.87e-06	7.02e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—NOS3—asthma	7.83e-06	6.98e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PDGFB—asthma	7.71e-06	6.88e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—TGFB1—asthma	7.55e-06	6.73e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—NQO1—asthma	7.53e-06	6.72e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—POMC—asthma	7.51e-06	6.71e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GSTT1—asthma	7.48e-06	6.68e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—IL2—asthma	7.44e-06	6.64e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—EGFR—asthma	7.4e-06	6.6e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—LEP—asthma	7.38e-06	6.58e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ADCY2—asthma	7.37e-06	6.58e-05	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—IL6—asthma	7.32e-06	6.53e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PTGS2—asthma	7.31e-06	6.52e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ALOX5—asthma	7.29e-06	6.5e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL1B—asthma	7.28e-06	6.49e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CD4—asthma	7.27e-06	6.49e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL2—asthma	7.25e-06	6.47e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PTGS2—asthma	7.22e-06	6.44e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CD4—asthma	7.21e-06	6.43e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PTGS2—asthma	7.16e-06	6.39e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CXCL8—asthma	7.09e-06	6.32e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FN1—asthma	6.96e-06	6.21e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CARM1—asthma	6.95e-06	6.2e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—DCN—asthma	6.85e-06	6.11e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ALB—asthma	6.85e-06	6.11e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—PTEN—asthma	6.82e-06	6.09e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL2—asthma	6.77e-06	6.04e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ALDH2—asthma	6.66e-06	5.95e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ALOX15—asthma	6.61e-06	5.9e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ALOX5AP—asthma	6.61e-06	5.9e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—POMC—asthma	6.61e-06	5.9e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—NOS3—asthma	6.55e-06	5.85e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MMP9—asthma	6.41e-06	5.72e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—asthma	6.41e-06	5.72e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—PTEN—asthma	6.37e-06	5.69e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PTEN—asthma	6.37e-06	5.69e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GSTT1—asthma	6.34e-06	5.66e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—POMC—asthma	6.34e-06	5.66e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—VEGFA—asthma	6.32e-06	5.64e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CHAT—asthma	6.31e-06	5.63e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PTEN—asthma	6.3e-06	5.62e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GSTP1—asthma	6.28e-06	5.61e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PTEN—asthma	6.24e-06	5.57e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—NQO1—asthma	6.22e-06	5.55e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCL2—asthma	6.2e-06	5.53e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—HMOX1—asthma	6.2e-06	5.53e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL6R—asthma	6.18e-06	5.52e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ITPR1—asthma	6.18e-06	5.52e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CAT—asthma	6.11e-06	5.45e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—STAT3—asthma	6.1e-06	5.44e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ADCY2—asthma	6.09e-06	5.43e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—EGFR—asthma	6.07e-06	5.41e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ALB—asthma	6.03e-06	5.38e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PTGS2—asthma	5.99e-06	5.35e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—asthma	5.84e-06	5.21e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TGFB1—asthma	5.8e-06	5.18e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SERPINE1—asthma	5.79e-06	5.17e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PLA2G4A—asthma	5.77e-06	5.15e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GSTM1—asthma	5.77e-06	5.15e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—NOS3—asthma	5.77e-06	5.15e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—VEGFA—asthma	5.76e-06	5.14e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—STAT3—asthma	5.7e-06	5.09e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—IL6—asthma	5.69e-06	5.07e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—STAT3—asthma	5.63e-06	5.03e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ALOX5—asthma	5.62e-06	5.02e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—RHOA—asthma	5.59e-06	4.98e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—STAT3—asthma	5.58e-06	4.98e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—EGFR—asthma	5.54e-06	4.95e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NOS3—asthma	5.53e-06	4.93e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CARM1—asthma	5.37e-06	4.79e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PPP2CA—asthma	5.32e-06	4.74e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—DCN—asthma	5.29e-06	4.72e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TGFB1—asthma	5.28e-06	4.71e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PTGS2—asthma	5.27e-06	4.71e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—NQO1—asthma	5.27e-06	4.7e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PTEN—asthma	5.23e-06	4.66e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—TGFB1—asthma	5.22e-06	4.66e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GSTP1—asthma	5.19e-06	4.63e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—EGFR—asthma	5.18e-06	4.62e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—TGFB1—asthma	5.17e-06	4.62e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ADCY2—asthma	5.16e-06	4.6e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ALDH2—asthma	5.14e-06	4.59e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—EGFR—asthma	5.12e-06	4.57e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—HMOX1—asthma	5.12e-06	4.56e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—asthma	5.11e-06	4.56e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ITPR1—asthma	5.1e-06	4.55e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—EGFR—asthma	5.07e-06	4.53e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CAT—asthma	5.05e-06	4.5e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CXCL8—asthma	4.9e-06	4.38e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GSTT1—asthma	4.89e-06	4.37e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PLA2G4A—asthma	4.77e-06	4.25e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GSTM1—asthma	4.77e-06	4.25e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL2—asthma	4.69e-06	4.18e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL6—asthma	4.66e-06	4.16e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PTEN—asthma	4.6e-06	4.1e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—asthma	4.46e-06	3.98e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MMP9—asthma	4.44e-06	3.96e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PTEN—asthma	4.41e-06	3.93e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GSTP1—asthma	4.39e-06	3.92e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PPP2CA—asthma	4.39e-06	3.92e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—HMOX1—asthma	4.33e-06	3.87e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ITPR1—asthma	4.32e-06	3.86e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CAT—asthma	4.28e-06	3.82e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL6—asthma	4.26e-06	3.8e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—POMC—asthma	4.08e-06	3.64e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—NQO1—asthma	4.07e-06	3.63e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PLA2G4A—asthma	4.04e-06	3.6e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GSTM1—asthma	4.04e-06	3.6e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—VEGFA—asthma	3.98e-06	3.55e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL6—asthma	3.98e-06	3.55e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ADCY2—asthma	3.98e-06	3.55e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—STAT3—asthma	3.94e-06	3.52e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—IL6—asthma	3.93e-06	3.51e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—IL6—asthma	3.9e-06	3.48e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PPP2CA—asthma	3.72e-06	3.32e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TGFB1—asthma	3.66e-06	3.26e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—EGFR—asthma	3.58e-06	3.2e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—NOS3—asthma	3.56e-06	3.18e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GSTP1—asthma	3.39e-06	3.03e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—POMC—asthma	3.37e-06	3.01e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—HMOX1—asthma	3.34e-06	2.98e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ITPR1—asthma	3.34e-06	2.98e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CAT—asthma	3.3e-06	2.94e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PTGS2—asthma	3.25e-06	2.9e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GSTM1—asthma	3.12e-06	2.78e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PLA2G4A—asthma	3.12e-06	2.78e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ALB—asthma	3.07e-06	2.74e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—NOS3—asthma	2.94e-06	2.62e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PPP2CA—asthma	2.87e-06	2.56e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—POMC—asthma	2.85e-06	2.55e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PTEN—asthma	2.84e-06	2.53e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL6—asthma	2.75e-06	2.46e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PTGS2—asthma	2.69e-06	2.4e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ALB—asthma	2.6e-06	2.32e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—NOS3—asthma	2.49e-06	2.22e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PTEN—asthma	2.34e-06	2.09e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PTGS2—asthma	2.28e-06	2.03e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—POMC—asthma	2.2e-06	1.97e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ALB—asthma	2.01e-06	1.79e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PTEN—asthma	1.99e-06	1.77e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—NOS3—asthma	1.92e-06	1.71e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PTGS2—asthma	1.76e-06	1.57e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PTEN—asthma	1.53e-06	1.37e-05	CbGpPWpGaD
